Stanley Druckenmiller acquired 159 Thousand Ascendis Pharma A/S shares worth $27.5 Million. That's 0.80% of their equity portfolio (32nd largest holding). Stanley Druckenmiller started to build up the position in Ascendis Pharma A/S in Q3 2024. Since then they sold 106 Thousand shares. The stake costed the investor $21.4 Million, netting the investor a gain of 28% so far.